• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge

    11/1/23 12:38:14 PM ET
    $CLLS
    $IRIX
    $PATI
    $PAYC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $CLLS alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.

    The Dow traded up 0.55% to 33,233.33 while the NASDAQ rose 0.87% to 12,962.92. The S&P 500 also rose, gaining, 0.74% to 4,224.85.

    Check This Out: $2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

     

    Leading and Lagging Sectors

     

    Information technology shares jumped by 1.3% on Wednesday.

    In trading on Wednesday, utilities shares fell by 0.1%.

     

    Top Headline

     

    The ISM manufacturing PMI fell to 46.7 in October versus 49 in the prior month, compared to market expectations of 49.

     

    Equities Trading UP

     

    Cellectis S.A. (NASDAQ:CLLS) shares shot up 148% to $2.3910. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.

    Shares of Patriot Transportation Holding, Inc. (NASDAQ:PATI) got a boost, shooting 104% to $15.69. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash.

    TG Therapeutics, Inc. (NASDAQ:TGTX) shares were also up, gaining 29% to $9.98 following third-quarter results.

     

    Equities Trading DOWN

     

    WeWork Inc. (NYSE:WE) shares dropped 52% to $1.09 following reports that the company is nearing bankruptcy.

    Shares of IRIDEX Corporation (NASDAQ:IRIX) were down 43% to $1.8669. Iridex has withdrawn its previously announced annual guidance for 2023 and plans to provide additional information during its third-quarter earnings release based on the information available at that time.

    Paycom Software, Inc. (NYSE:PAYC) was down, falling 38% to $153.11. Paycom Software reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below estimates.

    Also Check This Out: Top 3 Consumer Stocks That Could Sink Your Portfolio In Q4

     

    Commodities

     

    In commodity news, oil traded up 2.2% to $82.81 while gold traded up 0.3% at $1,999.60.

    Silver traded up 0.4% to $23.052 on Wednesday while copper rose 1% to $3.6850.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 gained 0.73%, London’s FTSE 100 rose 0.65% while Spain’s IBEX 35 Index rose 0.65% The German DAX gained 0.69% French CAC 40 climbed 0.68%, while Italy’s FTSE MIB Index jumped 0.99%.

    The S&P Global/CIPS UK manufacturing PMI was revised lower to 44.8 in October from the preliminary reading of 45.2, while Nationwide House Price Index fell by 3.3% year-over-year in October.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 rising 2.41%, Hong Kong’s Hang Seng Index falling 0.06% and China’s Shanghai Composite Index gaining 0.14%. India’s S&P BSE Sensex, meanwhile, slipped around 0.4%.

    Retail sales in Hong Kong surged 10.1% year-over-year in September versus a 11% increase in the prior month. The S&P Global India manufacturing PMI fell to 55.5 in October from 57.5, while the Caixin China general manufacturing PMI declined to 49.5 in October from 50.6 in the previous month. The au Jibun Bank Japan manufacturing PMI was revised higher to 48.7 in October.

     

    Economics

     

    Private businesses in the U.S. added 113,000 workers in October, compared to market estimates of a 150,000 increase and versus a gain of 89,000 in the prior month.

    Construction spending in the U.S. increased by 0.4% month-over-month to an annual rate of $1,996.5 billion in September.

    The number of job openings rose by 56,000 from the prior month to 9.55 million in September.

    The S&P Global manufacturing PMI rose to 50.0 in October from 49.8 in September.

    The ISM Manufacturing PMI fell to 46.7 in October versus 49 in the prior month, compared to market expectations of 49.

    Now Read This: These 3 Real Estate Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

    Get the next $CLLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLLS
    $IRIX
    $PATI
    $PAYC

    CompanyDatePrice TargetRatingAnalyst
    Cellectis S.A.
    $CLLS
    2/17/2026$7.00Buy
    Jefferies
    Paycom Software Inc.
    $PAYC
    2/12/2026$175.00 → $137.00Market Perform
    BMO Capital Markets
    Paycom Software Inc.
    $PAYC
    12/17/2025$195.00Buy
    BTIG Research
    TG Therapeutics Inc.
    $TGTX
    10/6/2025$60.00Buy
    H.C. Wainwright
    Paycom Software Inc.
    $PAYC
    9/26/2025$270.00Buy
    Guggenheim
    Paycom Software Inc.
    $PAYC
    9/22/2025$258.00Hold → Buy
    TD Cowen
    Paycom Software Inc.
    $PAYC
    8/14/2025$230.00Neutral
    Cantor Fitzgerald
    Paycom Software Inc.
    $PAYC
    8/7/2025$244.00 → $258.00Market Perform
    BMO Capital Markets
    More analyst ratings

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Dizon Romeo R bought $2,942 worth of shares (2,200 units at $1.34), increasing direct ownership by 2% to 119,890 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/17/26 12:55:35 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $2,145 worth of shares (1,500 units at $1.43), increasing direct ownership by 1% to 117,690 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/12/26 10:05:32 AM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $1,460 worth of shares (1,000 units at $1.46), increasing direct ownership by 0.87% to 116,190 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/10/26 3:19:41 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET to discuss results for the fourth quarter and full year 2025 and to provide a business outlook for 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com.

    2/23/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Paycom Promotes Shane Hadlock to President

    Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the promotion of Shane Hadlock to president, effective immediately. Hadlock will serve as president and chief client officer, overseeing the company's strategic operations, cross-functional alignment and continued execution of Paycom's full-solution automation strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260219831995/en/Paycom announces the promotion of Shane Hadlock to president. "Shane has been instrumental in driving meaningful outcomes for our clients and our business,

    2/19/26 9:10:00 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis

    During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50 years of patient treatment Overall safety profile of BRIUMVI remained consistent over 5 years of continuous treatment, with no new safety signals emerging with prolonged treatment NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the publication of long term/five-year data from the ongoing open-label extension (OLE) of the Phase 3 ULTIMATE I and II studies evaluating BRIUMVI (ublituximab-xiiy) in adults with relapsing forms of multiple sclerosis (RMS). The manuscript, authored by Bruce A. C. Cree, MD, PhD, MAS, of the U

    2/17/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Sales Officer York Jeffrey D. was granted 13,967 shares (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/20/26 4:05:03 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Foster Robert D. was granted 17,957 shares, increasing direct ownership by 90% to 37,809 units (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/20/26 4:05:06 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Peck Randall was granted 9,976 shares, increasing direct ownership by 21% to 58,191 units (SEC Form 4)

    4 - Paycom Software, Inc. (0001590955) (Issuer)

    2/20/26 4:05:03 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    SEC Filings

    View All

    SEC Form 10-K filed by Paycom Software Inc.

    10-K - Paycom Software, Inc. (0001590955) (Filer)

    2/19/26 4:11:12 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Amendment: Paycom Software Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K/A - Paycom Software, Inc. (0001590955) (Filer)

    2/19/26 10:40:45 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Software Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Paycom Software, Inc. (0001590955) (Filer)

    2/19/26 9:15:24 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Cellectis with a new price target

    Jefferies resumed coverage of Cellectis with a rating of Buy and set a new price target of $7.00

    2/17/26 7:48:16 AM ET
    $CLLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BMO Capital Markets reiterated coverage on Paycom Software with a new price target

    BMO Capital Markets reiterated coverage of Paycom Software with a rating of Market Perform and set a new price target of $137.00 from $175.00 previously

    2/12/26 6:46:23 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    BTIG Research resumed coverage on Paycom Software with a new price target

    BTIG Research resumed coverage of Paycom Software with a rating of Buy and set a new price target of $195.00

    12/17/25 9:25:02 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Financials

    Live finance-specific insights

    View All

    TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held, Thursday, February 26, 2026, at 8:30 AM ET to discuss results for the fourth quarter and full year 2025 and to provide a business outlook for 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com.

    2/23/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Paycom Software, Inc. Reports Fourth Quarter and Year-End 2025 Results

    Full Year Revenues of $2,052 million, up 9% year-over-year Full Year GAAP Net Income of $453 million, representing 22% of total revenues, or $8.08 per diluted share Full Year Non-GAAP Net Income of $519 million, or $9.24 per diluted share Full Year Adjusted EBITDA of $882 million, representing 43% of total revenues Paycom Software, Inc. ("Paycom," "we" and "our") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, today announced its financial results for the quarter and year ended December 31, 2025. "We delivered strong results in 2025, exceeding our strategic and financial goals for the year by driving full solution automation and str

    2/11/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Announces Quarterly Cash Dividend

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, announced today that its Board of Directors declared a cash dividend in the amount of $0.375 per share of common stock, to be paid on March 23, 2026, to all stockholders of record as of the close of business on March 9, 2026. About Paycom Paycom Software, Inc. (NYSE:PAYC) simplifies business and employees' lives through automated, command-driven HR and payroll technology that revolutionizes data access. From hire to retire, Paycom's employee-first technology leverages AI and full-solution automation to streamline processes and drive efficiencies in a truly si

    2/10/26 5:00:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Leadership Updates

    Live Leadership Updates

    View All

    Paycom promotes Shane Hadlock to lead IT; appoints Rachael Gannon to chief automation officer

    Brad Smith named senior technical strategist Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the expanded role of Shane Hadlock as Paycom's chief client officer and chief technology officer and the promotion of Rachael Gannon to chief automation officer, effective Aug. 18. Brad Smith has been named the company's senior technical strategist and will continue reporting to CEO Chad Richison. As chief technology officer, Hadlock will oversee Paycom's IT department, while maintaining his chief client officer role and leadership of Paycom's client service groups. "Shane's exceptional client-cen

    8/18/25 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

    EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage program following encouraging results from its Phase 1 study of TOS-358, a covalent PI3Kα inhibitor. "The addition of Simon, with over 15 years' experience in private capital markets strategy and IPO processes, comes at the right time for Totus as we advance our clinical-stage and discovery programs," said

    1/28/25 8:00:00 AM ET
    $CBUS
    $CLLS
    $MGX
    Agricultural Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Joe Binz Appointed to Paycom's Board of Directors

    Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the appointment of Joe Binz to Paycom's board of directors, effective Dec. 10, 2024. Binz currently serves as chief financial officer at Atlassian, where he is responsible for its global finance organization and oversees the company's accounting, finance, internal audit, investor relations, tax, treasury and procurement teams. He has more than 30 years of financial leadership experience in the technology industry. Prior to joining Atlassian, Binz held management roles at Microsoft, where he led the company's finance functions and guided its bu

    12/12/24 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $PATI
    $PAYC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by TG Therapeutics Inc.

    SC 13G/A - TG THERAPEUTICS, INC. (0001001316) (Subject)

    11/14/24 7:45:34 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Paycom Software Inc.

    SC 13G - Paycom Software, Inc. (0001590955) (Subject)

    11/14/24 4:07:41 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology